Literature DB >> 10157425

Modelling programme costs in economic evaluation.

P Fenn1, A McGuire, M Backhouse, D Jones.   

Abstract

Mesh:

Year:  1996        PMID: 10157425     DOI: 10.1016/0167-6296(95)00016-x

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


× No keyword cloud information.
  6 in total

1.  Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study duration.

Authors:  Martin E Backhouse
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

2.  [Telephone coaching for depression].

Authors:  W Gerlach-Reinholz; L Drop; E Basic; M Rauchhaus; J Fritze
Journal:  Nervenarzt       Date:  2017-07       Impact factor: 1.214

3.  Estimating long-term cost savings from treatment of Alzheimer's disease. A modelling approach.

Authors:  P Fenn; A Gray
Journal:  Pharmacoeconomics       Date:  1999-08       Impact factor: 4.981

4.  Estimating mean total costs in the presence of censoring: a comparative assessment of methods.

Authors:  Tracey A Young
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Appraising the economic efficiency of cancer treatment: an exploratory analysis of lung cancer.

Authors:  Thomas N Chirikos
Journal:  Health Care Manag Sci       Date:  2003-05

6.  Randomised controlled trial of laparoscopic versus open mesh repair for inguinal hernia: outcome and cost.

Authors:  J Wellwood; M J Sculpher; D Stoker; G J Nicholls; C Geddes; A Whitehead; R Singh; D Spiegelhalter
Journal:  BMJ       Date:  1998-07-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.